| Target Price consensus revisions : last 18 months |
|
|
|
| Evolution of the average Target Price on MERCK & CO., INC. |
|
|
|
Financial data source
© 2020 S&P Global Market Intelligence
|
|
|
Merck to move COVID-19 treatment into large trials, sees sales recovering this year |
|
MERCK AND COMPANY
Leader in oncology, modest valuation |
| Mean consensus |
BUY |
| Number of Analysts |
21 |
| Average target price |
96,15 $ |
| Last Close Price |
75,89 $ |
| Spread / Highest target |
41,0% |
| Spread / Average Target |
26,7% |
| Spread / Lowest Target |
12,0% |
Consensus revision (last 18 months)
|
Canada
Deutschland
France
Schweiz (DE)
United Kingdom
Report
